image_pdfimage_print

Inovio Updates on MedImmune Combination Trial for HPV-associated Head & Neck Cancer

Inovio Pharmaceuticals, Inc. {NASDAQ: INO} today announced that  MedImmune, AstraZeneca’s global biologics research and development arm, will start a new clinical trial investigating the combination of MEDI0457, an immunotherapy designed to generate antigen specific killer T cell responses targeting HPV-associated tumors, and durvalumab, an investigational PD-L1 checkpoint inhibitor. Continue reading

Inovio and Regeneron announce a clinical study for a immuno-oncology trial

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a clinical study agreement for a phase 1b/2a immuno-oncology trial.

The study will be conducted by Inovio in patients with newly diagnosed glioblastoma multiforme (GBM) and will evaluate Regeneron’s PD-1 inhibitor, REGN2810, in combination with Inovio’s INO-5401 T cell activating immunotherapy encoding multiple antigens and INO-9012, an immune activator encoding IL-12.  Continue reading

Cartier Resources Announces $6.0 Million Bought Deal Private Placement

Cartier Resources Inc. {TSX.V: ECR} is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (the “Lead Underwriter”), and including Paradigm Capital Inc.in connection with a bought deal private placement of common shares of the Company pursuant to which the Underwriters will purchase 22,250,000 common shares of the Company at a price of $0.27 per Offering Share to raise aggregate gross proceeds of $6,007,500. Continue reading

Scorpio Gold Commences Milling of Lode-Star Ore at its Goldwedge Property

Scorpio Gold Corporation {TSX-V: SGN} announced the milling of Lode-Star Mining Inc. ore at the Company’s Goldwedge processing facility, located 54 km north of Tonopah in Manhattan, Nevada, and 120 km north of Lode-Star’s Goldfield Bonanza property.

As previously announced in the Company’s February 21, 2017 news release, testing was conducted on Lode Star ore delivered to the Goldwedge milling facility. Continue reading

Cascadero update on their Cesium project in Argentina

Cascadero Copper Corp. {TSX.V: CCD} updated shareholders on its Taron Cesium occurrence in Salta Province, Argentina.

The diamond drilling program is more than halfway completed as 17 of the 29 proposed holes are drilled. Recoveries of core are improved as expected with the use of triple tube coring and the program is on schedule for completion at the end of May. Continue reading